You are here

Media Coverage

December 12, 2018
Rolling Stone

Researchers have long used stem cells and fetal matter to test potential HIV/AIDS medications, but the current US administration could put an end to that. Warner Greene speaks to Rolling Stone about how fetal tissue has become a standard tool in modern biomedical research, and how a ban on this tissue could negatively impact science.

December 11, 2018

The National Institutes of Health (NIH) announced that it will soon embark on a major research effort to find scientific alternatives to human fetal tissue, as a result of the recent directive from the US Department of Health and Human Services for internal NIH scientists to stop procuring human fetal tissue for use in research. Warner Greene tells TIME why the administration's decision has been devastating for his research program.

December 11, 2018
The Washington Post

The Washington Post reports that the US administration has shut down at least one government-run study that uses fetal tissue implanted into mice even before federal health officials reach a decision on whether to continue such research. Warner Greene, who was a collaborator on that study, describes how this could impact his research for an HIV cure.

December 9, 2018

Researchers at the National Institutes of Health (NIH) have been ordered not to acquire new fetal tissue for their research since September, as the US administration began an audit of  using the tissue funded by the NIH and other agencies. STAT News asks Warner Greene how this will affect his research to  examine how HIV reservoirs get established.

December 7, 2018

The US administration has ordered scientists employed by the National Institutes of Health to stop acquiring new human fetal tissue for experiments, reports ScienceInsider. Warner Greene explains how this has impacted his HIV research and the scientific field.

November 26, 2018

This article by WIRED magazine describes work at Gladstone by Bruce Conklin, Jennifer Doudna, and Todd McDevitt to establish the epicenter of a whole new field of medicine: genome surgery. Their efforts are perhaps the most concentrated push in a national effort to create the tools and rules necessary for doctors to widely adopt genome editing as part of standard care for the 25 million Americans estimated to be living with one of 6,000 diseases caused by a glitch in their DNA.

November 26, 2018
Good Morning America

Jennifer Doudna expresses concern that a scientist claiming to have created the first gene-edited babies broke from the international consensus within the scientific community calling for an open and transparent approach for any clinical use of human embryo editing.

In its weekly health care digest, the San Francisco Business Times highlights the new laboratory set up at Gladstone by Seth Shipman, whose work combines synthetic biology, genetics and neuroscience.

November 8, 2018
NIH Director's Blog

In his blog, NIH Director Francis Collins describes work by Bruce Conklin. He and his colleagues at UC Berkeley developed a new model that can mimic different degrees of stress that the heart may experience, for example, during exercise or in a person with high blood pressure.

October 23, 2018
Medium / UCSF Magazine

This post on Medium describes efforts at Gladstone by Jennifer Doudna and Bruce Conklin to bring CRISPR genome editing tools into the clinic to cure disease using an approach coined “genome surgery.”